🇺🇸 FDA
Patent

US 7081524

O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates

granted A61PA61P11/00A61P15/10

Quick answer

US patent 7081524 (O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P11/00, A61P15/10, A61P29/00, A61P31/00